Abstract
Aim: To determine whether the Framingham function accurately predicts the 10 year risk of coronary disease and to adapt this predictive method to the characteristics of a Spanish population.
Method and Results: A Framingham function for predicting 10 year coronary deaths and non-fatal myocardial infarction was applied to the population of the province of Gerona, Spain, where the cumulated incidence rate of myocardial infarction has been determined since 1988 by a specific registry. The prevalence of cardiovascular risk factors in this region of Spain was established in 1995 by a cross sectional study on a representative sample of 1748 people. The number of cases estimated by the Framingham function for 10 year coronary deaths and non-fatal myocardial infarction was compared with that observed. The Framingham function estimated 2425 coronary heart disease cases in women and 1181 were observed. In men, 9919 were estimated and 3706 were observed. Recalibrating the Framingham equations to the event rate and the prevalence of the risk factors in Gerona led to estimates very close to the number of cases observed in Gerona men and women.
Conclusions: The Framingham function estimates more than doubled the actual risk of coronary disease observed in north east Spain. After calibration, the Framingham function became an effective method of estimating the risk in this region with low coronary heart disease incidence.
Full Text
The Full Text of this article is available as a PDF (134.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Artaud-Wild S. M., Connor S. L., Sexton G., Connor W. E. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation. 1993 Dec;88(6):2771–2779. doi: 10.1161/01.cir.88.6.2771. [DOI] [PubMed] [Google Scholar]
- D'Agostino R. B., Sr, Grundy S., Sullivan L. M., Wilson P., CHD Risk Prediction Group Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001 Jul 11;286(2):180–187. doi: 10.1001/jama.286.2.180. [DOI] [PubMed] [Google Scholar]
- Dobson A. J., Evans A., Ferrario M., Kuulasmaa K. A., Moltchanov V. A., Sans S., Tunstall-Pedoe H., Tuomilehto J. O., Wedel H., Yarnell J. Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. World Health Organization. Monitoring trends and determinants in cardiovascular diseases. Ann Med. 1998 Apr;30(2):199–205. doi: 10.3109/07853899808999404. [DOI] [PubMed] [Google Scholar]
- Grundy S. M., Balady G. J., Criqui M. H., Fletcher G., Greenland P., Hiratzka L. F., Houston-Miller N., Kris-Etherton P., Krumholz H. M., LaRosa J. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation. 1998 May 12;97(18):1876–1887. doi: 10.1161/01.cir.97.18.1876. [DOI] [PubMed] [Google Scholar]
- Haq I. U., Jackson P. R., Yeo W. W., Ramsay L. E. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet. 1995 Dec 2;346(8988):1467–1471. doi: 10.1016/s0140-6736(95)92477-9. [DOI] [PubMed] [Google Scholar]
- Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ. 2000 Mar 11;320(7236):709–710. doi: 10.1136/bmj.320.7236.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kannel W. B., Larson M. Long-term epidemiologic prediction of coronary disease. The Framingham experience. Cardiology. 1993;82(2-3):137–152. doi: 10.1159/000175864. [DOI] [PubMed] [Google Scholar]
- Kannel W. B. Silent myocardial ischemia and infarction: insights from the Framingham Study. Cardiol Clin. 1986 Nov;4(4):583–591. [PubMed] [Google Scholar]
- Masiá R., Pena A., Marrugat J., Sala J., Vila J., Pavesi M., Covas M., Aubó C., Elosua R. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health. 1998 Nov;52(11):707–715. doi: 10.1136/jech.52.11.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Menotti A., Puddu P. E., Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000 Mar;21(5):365–370. doi: 10.1053/euhj.1999.1864. [DOI] [PubMed] [Google Scholar]
- Ordovas J. M. Colesterol y tabaco: clásicos que perduran en el tiempo. Rev Esp Cardiol. 2001 Oct;54(10):1143–1145. doi: 10.1016/s0300-8932(01)76471-8. [DOI] [PubMed] [Google Scholar]
- Pérez G., Pena A., Sala J., Roset P., Masiá R., Marrugat J. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. REGICOR Investigators. Int J Epidemiol. 1998 Aug;27(4):599–604. doi: 10.1093/ije/27.4.599. [DOI] [PubMed] [Google Scholar]
- Ramsay L. E., Haq I. U., Jackson P. R., Yeo W. W., Pickin D. M., Payne J. N. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet. 1996 Aug 10;348(9024):387–388. doi: 10.1016/s0140-6736(96)05516-x. [DOI] [PubMed] [Google Scholar]
- Sytkowski P. A., D'Agostino R. B., Belanger A., Kannel W. B. Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol. 1996 Feb 15;143(4):338–350. doi: 10.1093/oxfordjournals.aje.a008748. [DOI] [PubMed] [Google Scholar]
- Tomás-Abadal L., Varas-Lorenzo C., Bernades-Bernat E., Balaguer-Vintró I. Coronary risk factors and a 20-year incidence of coronary heart disease and mortality in a Mediterranean industrial population. The Manresa Study, Spain. Eur Heart J. 1994 Aug;15(8):1028–1036. doi: 10.1093/oxfordjournals.eurheartj.a060624. [DOI] [PubMed] [Google Scholar]
- Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A. M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994 Jul;90(1):583–612. doi: 10.1161/01.cir.90.1.583. [DOI] [PubMed] [Google Scholar]
- Verschuren W. M., Jacobs D. R., Bloemberg B. P., Kromhout D., Menotti A., Aravanis C., Blackburn H., Buzina R., Dontas A. S., Fidanza F. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA. 1995 Jul 12;274(2):131–136. [PubMed] [Google Scholar]
- Wallis E. J., Ramsay L. E., Ul Haq I., Ghahramani P., Jackson P. R., Rowland-Yeo K., Yeo W. W. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ. 2000 Mar 11;320(7236):671–676. doi: 10.1136/bmj.320.7236.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson P. W., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B. Prediction of coronary heart disease using risk factor categories. Circulation. 1998 May 12;97(18):1837–1847. doi: 10.1161/01.cir.97.18.1837. [DOI] [PubMed] [Google Scholar]
- van den Hoogen P. C., Feskens E. J., Nagelkerke N. J., Menotti A., Nissinen A., Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med. 2000 Jan 6;342(1):1–8. doi: 10.1056/NEJM200001063420101. [DOI] [PubMed] [Google Scholar]